Vyome Holdings, Inc. (“Vyome”) (NASDAQ: HIND), a clinical-stage biopharmaceutical company focused on developing therapies for serious immuno-inflammatory and rare conditions, today announced key ...

Applied Digital (APLD) shares surged as high as 15% during morning market action on Thursday after its second quarter fiscal 2026 results topped estimates and the company revealed it was in advanced ...

LONDON, Jan 7 (Reuters) - GSK (GSK.L), opens new tab will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory applications, it said on ...

Jan 7 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

COPJ gained 109% in 2025 and grew from $37M to a top performer by equal-weighting 50 copper miners. JPMorgan projects copper at $12,075 per metric ton through 2026 driven by AI data center demand.

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) is one of the 12 best multibagger stocks to buy heading into 2026. Following encouraging updates from the ongoing Phase 1b PIONEER study evaluating pociredir ...

With strong 1-year returns and upside potential, Nektar Therapeutics (NASDAQ:NKTR) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026. Nektar Therapeutics ...

Deciphering the Data is a side quest added to ARC Raiders in the winter-themed Cold Snap update. This quest sends you to the Spaceport to find some important data, but the objectives can be hard to ...

A new study estimates the environmental impact of AI in 2025 and calls for more transparency from companies on their pollution and water consumption. A new study estimates the environmental impact of ...

With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s chances at an FDA approval in the indication are looking slimmer. That said, the ...